Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Cancer|July 28, 2011
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lungGilberto de Lima Lopes, Joel E Segel, Daniel S W Tan, et al.
Lung Cancer (Auckland, N.Z.)|March 29, 2021
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on CapmatinibAaron C Tan, Tracy J Loh, Xue Lin Kwang, et al.
Clinical Lung Cancer|September 7, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung CancerDirk De Ruysscher, Suresh Ramalingam, James Urbanic, et al.
Cancer Treatment Reviews|April 21, 2017
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacyTony S K Mok, Lucio Crino, Enriqueta Felip, et al.
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug developmentDaniel S W Tan, George V Thomas, Michelle D Garrett, et al.
Genome Research|July 15, 2020
Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor typesArnoud Boot, Alvin W T Ng, Fui Teen Chong, et al.
Stem Cells Translational Medicine|July 16, 2014
Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancerHui Sun Leong, Fui Teen Chong, Pui Hoon Sew, et al.
Oral Oncology|January 7, 2015
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastasesWeining Wang, Weng Khong Lim, Hui Sun Leong, et al.
Nature Reviews. Disease Primers|September 26, 2024
Non-small-cell lung cancerLizza E L Hendriks, Jordi Remon, Corinne Faivre-Finn, et al.
The Oncologist|September 13, 2021
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 TrialLori J Wirth, Bruce Robinson, Valentina Boni, et al.
Pageof 13